In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies are changing the way we treat patients with some types of cancer, policies being considered in Washington could delay access to care for individuals covered under Medicare. “While CAR-T therapies represent a…

As BIO’s President and CEO, who proudly represented the Philadelphia suburbs in Congress for 12 years, I am delighted to welcome you to the city I love for the 2019 BIO International Convention – our industry’s largest annual gathering. Philadelphia was the very first capital of the United States…

Just moments after it was announced the FDA had approved a new treatment for spinal muscular atrophy, Dr. Peter Bach was warning about a “break down” in the U.S. drug pricing system. It’s unfortunate Dr. Bach would respond to the discovery of a miracle cure for a fatal disease with such doom and…

BIO represents pioneers in the world’s most innovative industry. It’s our job to support and advocate for our members as they pursue cutting-edge scientific and technological advancements — from finding new ways to treat cancer to enhancing the very food we eat to creating a sustainable environment…

Writing for The Atlantic, Dr. Ezekiel Emanuel accuses the biopharmaceutical industry of being “deceptive” when it seeks to explain the cost of prescription drugs. But in making this claim, Dr. Emanuel is guilty of engaging in some of his own acts of deception. For starters, drug prices are not …

In celebration of International Women’s Day on March 8th, women across the globe are leading the charge for balance and equality. This year’s tagline and theme, #BalanceforBetter, seeks a more gender-balanced world through celebrating women’s achievements and raising awareness about bias. One event…

In recognition of Rare Disease Day, BIO’s Jim Greenwood shared commentary on LinkedIn celebrating the success of the Orphan Drug Act and highlighting the importance of preserving incentives to help spur the development of new drugs in this space. “The truth is, incentives provided by the ODA have…

Two of our most beloved breakfast beverages — coffee and orange juice — are under serious threat from disease, insects and climate change. But don’t be too alarmed. Scientists are looking at innovative new ways to protect and strengthen coffee plants and citrus trees. With gene editing and the…

It’s hard to miss the news coming from the Pacific Northwest. Every major media outlet is covering the latest measles outbreak. Social media feeds are loaded with real-time data as the virus continues to spread. And the state of Washington has officially declared a State of Emergency. In case the…

As part of the 90-day trade negotiations between the United States and China, today Chinese Vice Premier Liu He is in Washington to participate in bilateral trade talks with the Trump administration. One major component the Trump administration has pushed for in such trade talks is structural…